The FDA has granted CircuLite investigational device exemption approval to launch a clinical study of its SYNERGY Circulatory Support System, which uses an implanted canula to pump oxygenated blood in the heart. The device could provide hard-to-treat terminal patients with a minimally invasive alternative to bypass or open-heart surgery.

Full Story:

Related Summaries